Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2020 08:00 ET | Quelle: Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.

Organovo Holdings Founder Calls on Board of Directors to Accept Stockholders’ Opposition to the Illogical Merger With Tarveda Therapeutics

Believes Stockholders Sent a Loud and Clear Message at Special Meeting That They Oppose This Value-Destructive Combination Encourages Board of Directors to Heed Investor Feedback and Re-Focus...
31. März 2020 15:25 ET | Quelle: Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.

Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt

Viscient will turn its attention to 3D bioprinting lung tissue for infectivity research to assist global efforts to combat SARS-CoV-2, the novel coronavirus that causes COVID-19 Organovo failed to...
23. März 2020 15:30 ET | Quelle: Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.

Organovo Holdings Founder Issues Letter Regarding Alternative Paths to Illogical Merger With Tarveda Therapeutics to Stockholders

Intends to Vote "AGAINST" Proposed Merger With Tarveda Intends to vote “FOR” Reverse Stock Split and Against All Other Provisions Believes the Board, Which Has Presided Over Significant Value...
19. März 2020 14:36 ET | Quelle: Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.

Organovo Founder Issues Letter to Stockholders Regarding Major Missteps and Misjudgment of the Company’s Board of Directors

Intends to Vote "AGAINST" Proposed Merger With Tarveda Believes the Board Has a Track Record of Bad Decisions and Poor Business Judgment Since Mid-2017, Including Hiring a CEO Who Failed Stockholders...